Reserved for MRSA infections that cannot be treated with first-line agents
Monitor ANC due to risk of neutropenia
Not on Dialysis:
CrCl (mL/min) | Dose |
---|---|
>50 | 600 mg IV Q12h |
30-50 | 400 mg IV Q12h |
15-29 | 300 mg IV Q12h |
<15 | 200 mg IV Q12h |
Dialysis:
Dose | |
---|---|
CRRT | 400 mg IV Q12h |
Intermittent HD | 200 mg IV Q12h |
Not on Dialysis:
CrCl (mL/min) | Dose |
---|---|
>50 | 600 mg IV Q8h |
30-50 | 400 mg IV Q8h |
15-29 | 300 mg IV Q8h |
<15 | 200 mg IV Q8h |
Dialysis:
Dose | |
---|---|
CRRT | 400 mg IV Q8h |
Intermittent HD | 200 mg IV Q8h |